Pirfenidone for Diabetic Nephropathy

Pirfenidone is an oral antifibrotic agent that benefits diabetic nephropathy in animal models, but whether it is effective for human diabetic nephropathy is unknown. We conducted a randomized, double-blind, placebo-controlled study in 77 subjects with diabetic nephropathy who had elevated albuminuri...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sharma, Kumar, Ix, Joachim H., Mathew, Anna V., Cho, Monique, Pflueger, Axel, Dunn, Stephen R., Francos, Barbara, Sharma, Shoba, Falkner, Bonita, McGowan, Tracy A., Donohue, Michael, RamachandraRao, Satish, Xu, Ronghui, Fervenza, Fernando C., Kopp, Jeffrey B.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Nephrology 2011
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103734/
https://ncbi.nlm.nih.gov/pubmed/21511828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010101049
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы